Further landmarks are new molecular diagnostic tests for Alzheimer dementia and prion diseases and recent neuroimmunological data of the HCNS that facilitate the development of innovative treatment strategies against multiple sclerosis and stroke.
In basic science, translational and clinical research, the HCNS has numerous regional, national and international collaborations with other university-level institutions (e.g., DESY, Max-Planck-Institute, National Institutes of Health, University College of London, Harvard Medical School) as well as private public partnerships.